Cargando…
Triphenylbutanamines: Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity†
[Image: see text] The human mitotic kinesin Eg5 represents a novel mitotic spindle target for cancer chemotherapy. We previously identified S-trityl-l-cysteine (STLC) and related analogues as selective potent inhibitors of Eg5. We herein report on the development of a series of 4,4,4-triphenylbutan-...
Autores principales: | Wang, Fang, Good, James A. D., Rath, Oliver, Kaan, Hung Yi Kristal, Sutcliffe, Oliver B., Mackay, Simon P., Kozielski, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428805/ https://www.ncbi.nlm.nih.gov/pubmed/22248262 http://dx.doi.org/10.1021/jm201195m |
Ejemplares similares
-
Optimized S-Trityl-l-cysteine-Based
Inhibitors of Kinesin Spindle Protein
with Potent in Vivo Antitumor Activity in Lung Cancer Xenograft Models
por: Good, James A. D., et al.
Publicado: (2013) -
Antibody–drug conjugates harboring a kinesin spindle protein inhibitor with immunostimulatory properties
por: Sommer, Anette, et al.
Publicado: (2022) -
Structural insights into human Kif7, a kinesin involved in Hedgehog signalling
por: Klejnot, Marta, et al.
Publicado: (2012) -
The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma
por: Hernández-García, Susana, et al.
Publicado: (2017) -
Kinesin-related proteins required for assembly of the mitotic spindle
Publicado: (1992)